Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 8, 1996, Pages 547-555

  Vatrella, A ^a,b,c   Ponticiello, A ^a,b,c   Parrella, R ^a,b,c   Romano, L ^a,b,c   Zofra, S ^a,b,c   Di Leva, A ^a,b,c   Bariffi, F ^a,b,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b MONALDI HOSPITAL   (Italy)

^c NONE   (Italy)

Author keywords

Allergens; Asthma; Bronchial hyperresponsiveness; Eosinophil cationic protein (ECP); Eosinophils; Inhaled corticosteroids; Methacholine challenge

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN; METHACHOLINE; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029819019     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb00111.x     Document Type: Article

References (25)

1. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991;87:893-910.
2. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989;139:806-17.
3. Laitinen LA, Laitinen AM, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993;147:697-704.
4. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
5. Laitinen LA, Laitinen A, Heino M, Haahtela T. Eosinophilic airway inflammation during exacerbation of asthma and its treatment with inhaled corticosteroid. Am Rev Respir Dis 1991;143:423-7.
6. Venge P, Henriksen J, Dahl R. Eosinophils in exerciseinduced asthma. J Allergy Clin Immunol 1991;88:699-704.
7. Adelroth E, Rosenhall L, Johansson S-A, Linden M, Venge P. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage: the effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis 1990;142:91-9.
8. Bousquet J, Chanez P, Lacoste JY, et al. Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol 1991;88:649-60.
9. Durham SR, Loegering DA, Dunnette S, Gleich GJ, Kay AB. Blood eosinophil-derived proteins in allergic asthma. J Allergy Clin Immunol 1989;84:931-6.
10. Carlson M, Hâkansson L, Peterson C, Stâlenheim G, Venge P. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol 1991;87:27-33.
11. Wever A, Wever-Hess J, Hensgens H, Hermans J. Serum eosinophil cationic protein (ECP) in chronic asthma. Relationship to spirometry, flow-volume curves, PCjg, and exacerbations. Respir Med 1994;88:613-21.
12. Zimmerman B, Lanner A, Enander I, Zimmerman RS, Peterson CGB, Ahlstedt S. Total blood eosinophils, serum eosinophil protein x in childhood asthma: relation to disease status and therapy. Clin Exp Allergy 1993;23:564-70.
13. Venge P, Dahl R, Peterson CGB. Eosinophil granule proteins in serum after allergen challenge of asthmatic patients and the effects of anti-asthmatic medication. Int Arch Allergy Appl Immunol 1988;87:306-12.
14. Ahlstedt S, Enander I, Peterson CGB, Lanner A. The clinical assessment of the inflammatory component in asthma with emphasis on the eosinophils. Pract Allergy Immunol 1993;8:149-54.
15. Peterson CGB, Enander I, Nystrand J, Anderson AS, Nilsson L, Venge P. Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clin Exp Allergy 1991;21:561-7.
16. Sugay T, Sakiyama Y, Matumoto S. Eosinophil cationic protein in peripheral blood of pédiatrie patients with allergic diseases. Clin Exp Allergy 1992;22:275-81.
17. Rak S, Lowhagen O, Venge P. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. J Allergy Clin Immunol 1988;82:470-80.
18. Carlson M, Hâkansson L, Kampe M, Stâlenheim G, Peterson C, Venge P. Degranulation of eosinophils from pollen atopic patients with asthma is increased during pollen season. J Allergy Clinjmmunol 1992;89:131-9.
19. Rak S, Bjornson A, Hâkansson L, Sorenson S, Venge P. The effect of immunotherapy on eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 1991;88:878-88.
20. Hedlin G, Ahlstedt S, Enander I, Hâkansson L, Venge P. Eosinophil cationic protein (ECP), eosinophil chemotactic activity (EGA), neutrophil chemotactic activity (NCA) and tryptase in serum before and during bronchial challenge in cat-allergic children with asthma. Pediatr Allergy Immunol 1992;3:144-9.
21. Mapp CE, Plebani M, Faggian D, et al. Eosinophil cationic protein (ECP), histamine and tryptase in peripheral blood before and during inhalation challenge with toluene diisocyanate (TDI) in sensitized subjects. Clin Exp Allergy 1994;24:730-6.
22. Boner AL, Peroni D, Seite L, Valletta EA, Piacentini G. Effects of allergen exposure-avoidance on inflammation in asthmatic children. Allergy 1993;48:119-24.
23. Juntunen-Backman K, Jarvinen P, Sorva R. Serum eosinophil cationic protein during treatment of asthma in children. J Allergy Clin Immunol 1993;92,:34-8.
24. Wempe JB, Tammeling EP, Koeter GH, Hâkansson L, Venge P, Postma DS. Blood eosinophil numbers and activity during 24 hours: effects of treatment with budesonide and bambuterol. J Allergy Clin Immunol 1992;90:757-65.
25. Evans PM, O'Connor BJ, Fuller RW, Barnes PJ, Chung KF. Effect of inhaled corticosteroids on peripheral eosinophil counts and density profile in asthma. J Allergy Clin Immunol 1993;91:643-50.